CIBMTR
@cibmtr.bsky.social
Research organization, collaborating with the global scientific community to increase survival and enrich quality of life for patients needing cellular therapy.
Learn more at cibmtr.org.
Learn more at cibmtr.org.
A special congratulations to Dr. Stella Davies, our #Tandem26 Mortimer M. Bortin lecturer! It is our pleasure to now hear, “Waiting until Evening to See How Splendid the Day Has Been: Aging and Transplant at the Extremes of the Lifespan” this evening!
February 7, 2026 at 12:17 AM
A special congratulations to Dr. Stella Davies, our #Tandem26 Mortimer M. Bortin lecturer! It is our pleasure to now hear, “Waiting until Evening to See How Splendid the Day Has Been: Aging and Transplant at the Extremes of the Lifespan” this evening!
Dr. Rachel Cusatis, CIBMTR Senior Scientific Director, is now presenting oral abstract, “Mismatch Doesn’t Mean Misfortune: Quality of Life after HCT in the ACCESS Trial,” at #Tandem26.
February 6, 2026 at 10:28 PM
Dr. Rachel Cusatis, CIBMTR Senior Scientific Director, is now presenting oral abstract, “Mismatch Doesn’t Mean Misfortune: Quality of Life after HCT in the ACCESS Trial,” at #Tandem26.
Have you had a chance to visit the #Tandem26 exhibit hall? Make sure to stop by the Tandem Meetings Hub to visit with CIBMTR staff! Open today until 3 p.m. and 9 a.m.-12 p.m. tomorrow!
February 6, 2026 at 6:17 PM
Have you had a chance to visit the #Tandem26 exhibit hall? Make sure to stop by the Tandem Meetings Hub to visit with CIBMTR staff! Open today until 3 p.m. and 9 a.m.-12 p.m. tomorrow!
A Wednesday session at #Tandem26 took a closer look at where gene therapy stands today—what’s working, what’s holding it back, and what’s coming next. Check out the full recap in Tandem Meeting News: www.tandemmeetingsnews.com/experts-disc...
February 6, 2026 at 5:30 PM
A Wednesday session at #Tandem26 took a closer look at where gene therapy stands today—what’s working, what’s holding it back, and what’s coming next. Check out the full recap in Tandem Meeting News: www.tandemmeetingsnews.com/experts-disc...
What's next for HCT and cellular therapies? The #Tandem26 opening-day plenary examined progress from breakthrough to bedside — looking toward equitable access and improved care. Read more in Tandem Meeting News: www.tandemmeetingsnews.com/joint-plenar...
February 6, 2026 at 4:20 PM
What's next for HCT and cellular therapies? The #Tandem26 opening-day plenary examined progress from breakthrough to bedside — looking toward equitable access and improved care. Read more in Tandem Meeting News: www.tandemmeetingsnews.com/joint-plenar...
Reposted by CIBMTR
#tandem26 #bmtsm Spellman: @cibmtr.bsky.social study shows equivalent GRFS w MRD and MUD but alternative donors far slightly worse. Avoid DPB1np mm in MUD, but this mm type *may* be protective in haplo.
February 5, 2026 at 5:51 PM
#tandem26 #bmtsm Spellman: @cibmtr.bsky.social study shows equivalent GRFS w MRD and MUD but alternative donors far slightly worse. Avoid DPB1np mm in MUD, but this mm type *may* be protective in haplo.
Reposted by CIBMTR
February 5, 2026 at 5:42 PM
Reposted by CIBMTR
#tandem26 #bmtsm Spellman: updated guidelines for donor selection from @cibmtr.bsky.social. Partially driven by massive expanded use of PTCy.
February 5, 2026 at 5:40 PM
#tandem26 #bmtsm Spellman: updated guidelines for donor selection from @cibmtr.bsky.social. Partially driven by massive expanded use of PTCy.
Reposted by CIBMTR
🔬 NMDP and CIBMTR are presenting new findings from the ACCESS study at #Tandem2026.
These new findings highlight important dimensions of transplant outcomes and patient experience following mismatched unrelated donor (MMUD) transplantation 👉 go.nmdp.org/Tandem2026
These new findings highlight important dimensions of transplant outcomes and patient experience following mismatched unrelated donor (MMUD) transplantation 👉 go.nmdp.org/Tandem2026
HLA Mismatch Levels Show Comparable Survival, PROs | NMDP
NMDP-sponsored ACCESS trial data presented at the 2026 Tandem Meetings show comparable patient-reported outcomes and survival, even for <7/8 matches. Read the results.
go.nmdp.org
February 4, 2026 at 10:00 PM
🔬 NMDP and CIBMTR are presenting new findings from the ACCESS study at #Tandem2026.
These new findings highlight important dimensions of transplant outcomes and patient experience following mismatched unrelated donor (MMUD) transplantation 👉 go.nmdp.org/Tandem2026
These new findings highlight important dimensions of transplant outcomes and patient experience following mismatched unrelated donor (MMUD) transplantation 👉 go.nmdp.org/Tandem2026
Attending #Tandem26 and looking for session locations in the Salt Palace Convention Center? Here are few helpful maps! @astct.bsky.social
February 4, 2026 at 10:39 PM
Attending #Tandem26 and looking for session locations in the Salt Palace Convention Center? Here are few helpful maps! @astct.bsky.social
Dr. Miguel-Angel Perales (@drmiguelperales.bsky.social) concludes the CIBMTR Concurrent Session with “Use of CIBMTR One Year Survival Calculator for Retrospective Analysis” at #Tandem26 this morning!
February 4, 2026 at 6:23 PM
Dr. Miguel-Angel Perales (@drmiguelperales.bsky.social) concludes the CIBMTR Concurrent Session with “Use of CIBMTR One Year Survival Calculator for Retrospective Analysis” at #Tandem26 this morning!
Drs. Doug Rizzo and Navneet Majhail (@bldcancerdoc.bsky.social) collaborate to chair the outstanding “Concurrent: Beyond the Report Card – Advancing Research and Quality through Center Specific Outcomes Reporting [CIBMTR]” this morning at #Tandem26
February 4, 2026 at 6:17 PM
Drs. Doug Rizzo and Navneet Majhail (@bldcancerdoc.bsky.social) collaborate to chair the outstanding “Concurrent: Beyond the Report Card – Advancing Research and Quality through Center Specific Outcomes Reporting [CIBMTR]” this morning at #Tandem26
Reposted by CIBMTR
It's not too late to add the NMDP/CIBMTR community to your #Tandem2026 agenda! Check out these notable presentations from the ACCESS Trial ⬇️
February 4, 2026 at 5:57 PM
It's not too late to add the NMDP/CIBMTR community to your #Tandem2026 agenda! Check out these notable presentations from the ACCESS Trial ⬇️
CIBMTR’s February 2026 Newsletter is out now! Catch new Perspectives, Working Committee updates, the latest Page Scholars, news from BMT CTN and ACT Corner, and a look ahead to the 2026 Tandem Meetings. Read here: cibmtr.org/CIBMTR/About...
February 3, 2026 at 3:21 PM
CIBMTR’s February 2026 Newsletter is out now! Catch new Perspectives, Working Committee updates, the latest Page Scholars, news from BMT CTN and ACT Corner, and a look ahead to the 2026 Tandem Meetings. Read here: cibmtr.org/CIBMTR/About...
CIBMTR's 2025 Annual Report is now available to view on our website. Thank you for helping us make 2025 another successful year! cibmtr.org/Files/Admini...
February 2, 2026 at 4:27 PM
CIBMTR's 2025 Annual Report is now available to view on our website. Thank you for helping us make 2025 another successful year! cibmtr.org/Files/Admini...
Experts say a 24-hour caregiver is not necessary for people who receive blood or marrow transplants. Read about this CIBMTR study to learn more: cibmtr.org/Patient-Summ...
January 21, 2026 at 9:29 PM
Experts say a 24-hour caregiver is not necessary for people who receive blood or marrow transplants. Read about this CIBMTR study to learn more: cibmtr.org/Patient-Summ...
HOUSING FRAUD ALERT: Attending #Tandem26? Book your 2026 Tandem Meetings housing only through onPeak using the info emailed to you. Ignore third-party offers and never share personal details. Questions? Contact [email protected].
December 29, 2025 at 3:19 PM
HOUSING FRAUD ALERT: Attending #Tandem26? Book your 2026 Tandem Meetings housing only through onPeak using the info emailed to you. Ignore third-party offers and never share personal details. Questions? Contact [email protected].
Final call! Tomorrow is the last day to submit late-breaking or federal investigator abstracts for #Tandem26. If you have new scientific findings or are a federal investigator, submit your abstract tomorrow, Dec. 23: www.tandemmeetings.com/Abstracts/Ab...
December 22, 2025 at 3:17 PM
Final call! Tomorrow is the last day to submit late-breaking or federal investigator abstracts for #Tandem26. If you have new scientific findings or are a federal investigator, submit your abstract tomorrow, Dec. 23: www.tandemmeetings.com/Abstracts/Ab...
The Tandem Meetings is now accepting late-breaking abstracts and abstracts from federal investigators! Eligible abstracts will be selected for oral presentation. Submit your HCT, cell and gene therapy research findings by Dec. 23: ow.ly/MwiC50XHtyJ@...
December 11, 2025 at 6:44 PM
The Tandem Meetings is now accepting late-breaking abstracts and abstracts from federal investigators! Eligible abstracts will be selected for oral presentation. Submit your HCT, cell and gene therapy research findings by Dec. 23: ow.ly/MwiC50XHtyJ@...
HOUSING FRAUD ALERT: Attending #Tandem26? Book your 2026 Tandem Meetings housing only through onPeak using the info emailed to you. Ignore third-party offers and never share personal details. Questions? Contact [email protected].
December 9, 2025 at 7:42 PM
HOUSING FRAUD ALERT: Attending #Tandem26? Book your 2026 Tandem Meetings housing only through onPeak using the info emailed to you. Ignore third-party offers and never share personal details. Questions? Contact [email protected].
Attending #ASH25 this weekend? If so, make sure to stop by the CIBMTR booth (#782) in the exhibit hall – for a special opportunity to save on your #Tandem26 registration! You can also view a list of all CIBMTR abstracts, here: cibmtr.org/Files/Meetin...
December 5, 2025 at 4:08 PM
Attending #ASH25 this weekend? If so, make sure to stop by the CIBMTR booth (#782) in the exhibit hall – for a special opportunity to save on your #Tandem26 registration! You can also view a list of all CIBMTR abstracts, here: cibmtr.org/Files/Meetin...